Method for treatment and diagnosis of IL-5 mediated disorders

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4241331, 4241411, 4241451, 435 71, 5303881, 53038823, A61K 39395, A61K 3940, G01N 3353, C07K 1600

Patent

active

057831840

ABSTRACT:
The present invention relates to treatment and diagnosis of conditions mediated by IL-5 and excess eosinophil production, and more specifically to mAbs and other altered antibodies such as Fabs, chimeric, human and humanized antibodies that do not block binding of human IL-5 to the .alpha.-chain of the human IL-5 receptor.

REFERENCES:
patent: 4980359 (1990-12-01), Hasspacker et al.
patent: 5455337 (1995-10-01), Devos et al.
Morrison et al (PNAS USA vol. 81 Nov. 1984 pp. 6851-6855).
McNamee et al (J. of Immunological Methods vol. 141 (1991) pp. 81-88).
Dickason, et al., "Delineation of IL-5 Domains Predicted to Engage the IL-5 Receptor Complex", J. Immunol., 156, pp. 1030-1037 (1996).
Dickason, et al., "Enhanced Detection of Human IL-5 In Biological Fluids Utilizing Murine Monoclonal Antibodies Which Delineate Distinct Neutralizing Epitopes", Cytokine, 6, pp. 647-656 (1994).
Cornelis, S., "Detailed analysis of the IL-5-IL-5R.alpha. interaction: characterization of crucial residues on the ligand and the receptor", The EMBO Journal, 14 pp. 3395-3402 (1995).
Tavernier, J., "Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist", Proc. Natl. Acad. Sci. USA, 92, pp. 5194-5198 (1995).
Graber, P., "Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation", The Journal of Biological Chemistry., 270, pp. 15762-15769 (1995).
Migita, M., "Characterization of the human IL-5 receptors on eosinophils", Cellular Immunology., 133, pp. 484-497 (1991).
Rolink, A., "Monoclonal Antibodies Reactive With the Mouse Interleukin 5 Receptor", J. Exp. Med., 169, 1693-1701 (1989).
Murata, Y., "Molecular Cloning and Expression of the Human Interleukin 5 Receptor", J. Exp. Med., 175, pp. 341-351 (1992).
Tavernier, J., "Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor .alpha. subunit", Proc. Natl. Sci. USA, 89, pp. 7041-7045 (1992).
Abrams, J., Eosinophil-active aytokines in human disease: development and use of monoclonal antibodies to IL3, IL5, and GM-CSF Eosinophilis in Allergy and Inflammation, pp. 133-157 (1994).
Banks, M., "Soluble Iterleukin 5 Receptor .alpha.-Chain Binding Assays: Use for Screening and Analysis of Interleukin-5 Mutants", Analytical Biochemistry, 230, pp. 321-328 (1995).
Johanson, K., "Binding Interactions of Human Interleukin 5 with its Receptor .alpha. Subunit", The Journal of Biological Chemistry, 270, pp. 9459-9471 (1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treatment and diagnosis of IL-5 mediated disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treatment and diagnosis of IL-5 mediated disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment and diagnosis of IL-5 mediated disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1644284

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.